Norelgestromin and ethinyl estradiol transdermal system (patch) is used to prevent pregnancy. Norelgestromin is a progestin and ethinyl estradiol is an estrogen. Estrogen and progestin are two female sex hormones. Norelgestromin and ethinyl estradiol contraceptive patch works by preventing ovulation (the release of eggs from the ovaries) and by changing the cervical mucus and the lining of the uterus. The contraceptive patch is a very effective method of birth control, but it does not prevent the spread of human immunodeficiency virus [HIV; the virus that causes acquired immunodeficiency syndrome (AIDS)] and other sexually transmitted diseases.
If you've used the ORTHO EVRA® Patch, you may be entitled to monetary compensation. Call Walker & Walker Attorney Network at 1-800-THE-LAW2 (1-800-843-5292) for your free consultation. Or fill out the FREE CONSULTATION box on the left of this page now.
Brand Names:
Source: National Institute of Health and American Society of Health-System Pharmacists, Inc.,“Norelgestromin and Ethinyl Estradiol Transdermal System", The MedMaster™ Patient Drug Information Database, 2007, http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602006.html (23 May 2007)
Warnings:
As of 11/14/2005 the FDA notified healthcare professionals and patients of revisions to the label for ORTHO EVRA®, a skin patch approved for birth control, that includes a bolded warning about higher exposure to estrogen for women using the weekly patch compared to taking a daily birth control pill containing 35 micrograms of estrogen. A woman on ORTHO EVRA® may be exposed to approximately 60% more estrogen than if she were taking a typical 35 microgram estrogen birth control pill. Estrogen use is linked to blood clots in the legs and lungs and other clotting problems such as strokes and heart attacks. It is not known if women using ORTHO EVRA® have a higher risk of serious side effects than women taking the typical 35 microgram estrogen pills.
Source: U.S. Food and Drug Administration, “Ortho Evra (norelgestromin/ethinyl estradiol transdermal system)", The FDA Saftey Information and Adverse Event Reporting Program, 2005, http://www.fda.gov/medwatch/SAFETY/2005/safety05.htm (30 May 2007)
For more information on drugs recently recalled by the U.S. Food and Drug Administration (FDA), please go to: US FDA: Recalls, Market Withdrawals and Safety Alerts.
ORTHO EVRA® Patch is a registered trademark of Ortho-McNeil-Janssen Pharmaceuticals, Inc.